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Introduction
The World Health Organization
declared that the rate of breast cancer
will increase by 50% globally.1 There
is no recent rate of disease incidence
in Nigeria other than the rate
computed by the International
Agency for Research on Cancer
(IARC) that obtained data derived
from three population-based registries
Abstract
Background: Breast cancer is a major global health problem in women from both
developing and developed countries. As the leading cause of death among women, breast
cancer has contributed 19.5% to the mortality rate among women in Nigeria. This study
investigated the trend of breast cancer among women who attended Federal Teaching
Hospital, Ido-Ekiti, Nigeria. 
Methods: This retrospective study examined the trend of breast cancer over a period
of eight years and determined the most affected age group. Participants consisted of
patients registered in the cancer registry who had histologically confirmed breast
cancer. Data of 362 patients were examined between March and April 2016. Data were
analyzed and presented using descriptive (frequency, charts, and percentages) and
inferential statistics (Fisher’s exact) for hypothesis testing. 
Results: Findings of this study revealed that the mean age of the participants was
45.04±16.94 years and all patients involved were females. The age group 20-39 years
was most affected by breast cancer with a proportion of 41.7%. This study revealed a
relationship between breast cancer classification and age of patients (P=0.011). Almost
all (94.3%) cases seen within this time period were malignant.
Conclusion: Healthcare professionals should place more emphasis on prevention
of breast cancer across all age groups, especially young adults. These young adults
constitute the larger percentage of the adult population. An increase in mortality rate
in this age group will reduce the labor force and affect the nation’s economy.
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in Nigeria (Abuja, Calabar, and Ibadan) in 2012.
According to the study, 26.7% (27304) women
with confirmed breast cancer were reported.2,3
As the leading cause of death among women,
breast cancer contributed 19.5% to the mortality
rate among women in Nigeria.2,3
Just like any other cancer, breast cancer occurs
as a result of interaction between the environment
and a genetically susceptible host. Cells become
cancerous when they compromise in their ability
to stop dividing, attaching to other cells to stay
where they belong, and die at the proper time.4
Breast cancer is the leading cause of death among
women with over one million new cases diagnosed
annually which results in over 400,000 deaths
annually.5
Breast cancer is a major health problem in
both developing and developed countries. It is
the most common invasive cancer in women
globally.6 Breast cancer can be defined as a
malignant disease that occurs when there is an
uncontrolled growth of abnormal cells in the
breast. This condition can be found in both males
and females but the rate of occurrence is more in
females. Normal cells will commit cell suicide
(apoptosis) when they are no longer needed. Until
then, cells are protected from suicide by several
protein clusters and pathways. It has been deduced
that sometimes the genes along these protective
pathways mutate in a way that turns them
permanently "on", rendering the cell incapable of
committing suicide when it is no longer needed.4
In our present age breast cancer is seen as the
number one cancer scourge that afflicts humans,
particularly women, and is the leading cause of
death and disability among women.7
Presently, in the United States, the incidence is
about 190,000 in women and 1,900 in men. More
than 40,000 deaths are recorded annually.8 In
African-American women, the rate of incidence
is almost the same as Caucasian women.9 In
Nigeria, the Medical Director of the Optimal
Cancer Care Foundation in Lagos has declared that
breast cancer kills one in every 25 Nigerian
women.10 It was reported that the 5-year survival
rate for breast cancer patients in the United States
exceeds 85%, but in Nigeria it is about 10%.10 The
incidence and overall mortality rates continue to
be lower in most high-income countries compared
to developing countries.11 The case fatality rates
are higher in developing countries which may be
attributed to lack of awareness of the benefits of
detection and treatment, scarcity of adequate
facilities for detection and diagnosis, and poor
access to primary treatment. In identification of
breast cancer, timing of exposure is important
with respect to mechanism and susceptibility.
In Nigeria, breast cancer constitutes a major
Figure 1. Breast cancer frequency per year in cases from the Federal Teaching Hospital, Ido-Ekiti (FETHI).
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public health issue. However, the available
statistics are largely unreliable because of
numerous factors that have not allowed for
adequate data collection and documentation. It is
therefore necessary to assess the trend of breast
cancer cases seen in a tertiary hospital in order to
facilitate an appropriate intervention program for
the mostly affected age group. The objective of this
study is to determine the trend of breast cancer in
a tertiary healthcare facility in Nigeria.
Materials and Methods
This retrospective study covered a period of
eight years (January, 2008-January, 2015). The
study was conducted at the Federal Teaching
Hospital, Ido-Ekiti (FETHI), Ekiti state, Nigeria,
a tertiary institution located in a rural area in
Ekiti-State, Nigeria. The Federal Teaching
Hospital, Ido-Ekiti is one of the two teaching
hospitals in this state. The hospital was established
in July, 1998 as a Federal Medical Center and later
upgraded to a teaching hospital in September,
2014 by the Federal Government of Nigeria. The
facility is located at Ido-Osi Local Government.
This hospital is a 280 bed institution that has 24
functional wards with other ancillary units such
as a Radiology Department, Laboratory, and
Pharmacy. 
We examined and analyzed all breast cancer
records available in the Histopathology Laboratory
at FEHTI. The study included all breast cancer
cases seen and diagnosed histologically in eight
years (January, 2008-January, 2015). We used
the total sampling frame as all available records
on the 326 cases seen within this time period.
The data were gathered between March and April
2016. We only used information from patients
who had histological diagnoses. Information on
patients’ records included age, gender, basis of
diagnosis, breast cancer type, and date of
diagnosis. Data were analyzed using Statistical
Package for Social Sciences (SPSS) version 20 at
the univariate and bivariate levels. Descriptive
statistics of frequency counts and percentages
were used for data analysis. Data were presented
in tables and charts with a significant P-value set
at <0.05. Bivariate analysis was carried out using
Figure 2. Breast cancer trend by age group.
Table 1. Age distribution of breast cancer cases seen at the
Federal Teaching Hospital, Ido-Ekiti (FETHI).
Age group (years)      Frequency Percentage
<20 3 0.8
20-29 85 23.5
30-39 66 18.2
40-49 62 17.1
50-59 56 15.5
60-69 53 14.7
≥70 37 10.2
Total 362 100
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Fisher’s exact test for discrete variables in testing
the hypothesis. The Ethical Review Board of
FEHTI, located in Ido-Ekiti, Nigeria, grated ethical
clearance. 
Results
Table 1 shows the demographic profile of
breast cancer cases seen at FETHI. The mean age
was 45±16.94 years. Almost half (42.5%) of the
women diagnosed with breast cancer were below
40 years of age and all cases were women (100%). 
From table 2, the most common breast cancer
types were: adenocarcinoma (18.2%), ductal
carcinoma (15.2%), malignant mastocytosis
(13.3%), fibrosarcoma (11.6%), and fibromyx-
osarcoma (11.1%). In this study, the majority
(94.3%) of breast cancers were malignant while
5.7% were benign. 
There was a statistically significant relationship
between age and breast cancer classification (Table 3).
Figure 1 shows that a higher percentage
(32.3%) of breast cancer cases in 2013 followed
by 2012 (19.3%) and 2014 (18.8%).
Discussion
Breast cancer and age
This study showed a decline in the number of
breast cancer cases with respect to age. The
findings of this study revealed that the most
affected age group was between 20-29 years of age
(Table 1). This finding has contradicted reports
such as a study in Ireland which showed the
highest incidence in women aged between 45-64;12
a 34.3% incidence among Singaporean women
aged 45-54 years between 2005-2009;13 and a
28% incidence among women aged 50-69 in
Norway.14 There are a number of known breast
cancer risk factors which include high
socioeconomic status;15 history of breast cancer in
a first degree relative;16 high doses of radiation
exposure;16,17 diethylstilbestrol exposure during
pregnancy;18 breast cancer (BRCA) genetic
mutations to BRCA1, BRCA2, and other breast
genes;16 low age at menarche and high age at
menopause;19 postmenopausal high body mass
index;20 lifestyle factors such as obesity, lack of
exercise, and alcohol use;16 and long-term use of
hormone replacement therapy.21 However, a
number of protective factors include low age at
first childbirth,19 high parity,19 and physical
activity.22,23 It is unknown what risk factors could
have increased the occurrence of breast cancer in
this young age group in the current study. The
general knowledge is that the risk of breast cancer
increases with age, with most cases that develop
in women after menopause.16 Tobacco use and
obesity are the most likely factors responsible
for breast cancer in Africa. Hence, they are the
most feasible, cost-effective approaches to cancer
control.24
In 1996, Gaudette et al. reported a rise in
incidence of breast cancer after the age of 30
years. The highest rates were among Canadian
women aged 60 and above.25 In 2001, the highest
incidence of breast cancer in Japan was among the
50-54 age group; in the US, it was among the 55-
59 age group in 2002.26 In both countries, the
number of new cases began to increase after the
age of 20 years, reached a peak at the age of 50-
59 and declined thereafter. In Egypt, from
1999-2008, the highest incidence rate of breast
Table 2. Breast cancer types seen at Federal Teaching Hospital,
Ido-Ekiti (FETHI).
Breast cancer type     Frequency Percentage
Adenocarcinoma 66 18.2
Fibromyxosarcoma 40 11.1
Malignant mastocytosis 48 13.3
Fibrosarcoma 42 11.6
Lump breast mass 6 1.7
Ductal carcinoma 55 15.2
Fibroadenoma 8 2.2
Fibrocystic disease 4 1.1
Medullary carcinoma 2 0.6
Metastatic carcinoma 5 1.4
Lobular carcinoma 2 0.6
Squamous cell carcinoma 6 1.7
Carcinoma simplex 5 1.4
Sclerosing adenosis 1 0.3
Lactating adenoma 1 0.3
Chronic granulomatous 1 0.3
mastitis
Other 12 3.3
Missing data 58 16.0
Total 362 100
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cancer was among women aged 40-49 years.
However, it has been projected that a significant
increase in breast cancer caseloads will be among
women aged 30-39 years by 2015.27 Our findings
have shown that the occurrence of breast cancer
peaked at the age of 20-29 and later declined
with increasing age. This calls for a refocus on the
target age group for breast cancer screening. The
occurrence of breast cancer at a young age could
result in women dying young despite the fact that
the life expectancy at birth in Nigeria is 48 years.28
This paradigm shift in breast cancer among female
age groups is alarming. The findings of this study
could actually be the tip of an iceberg. However,
other studies should be carried out to verify this
observation and determine if technological
advancement, sexual practices, early menarche,
carcinogens, and modern/Western lifestyle
behaviors have contributed to this observation
among young adults.
Breast cancer trend
In Nigeria, although breast cancer constitutes
a major public health problem, statistics are largely
unavailable and unreliable. In 2008, breast cancer
was the most common cancer among females in
Nigeria.25 The result obtained from this study
indicated that the breast cancer trend among
women from 2008 to 2015 did not show a specific
direction over these years (Figure 1). There was
a rise between 2008 and 2009, followed by a
decline in 2010. From 2010 to 2013, there was an
increase in the number of breast cancer cases
reported. From 2013 to 2015, we observed a
drastic decrease in the number of cases reported.
The trend reported by most developed countries
indicated a consistent decline in the incidence of
breast cancer. Early detection by mammography,
implementation of early treatment, and improved
therapeutic modalities were attributed to the recent
decrease in the mortality rate from breast cancer
in the US.26 The trend observed in this study
could have been influenced by lack of awareness,
lack of diagnostic instruments, lack of access to
hospital facilities and, more importantly, socio-
economic status. The number of breast cancer
cases for the 20-39 and above 40 age groups
peaked in 2013 (Figure 2).
Breast cancer type and classification
The most common types of breast cancer
reported were adenocarcinoma (18.2%), ductal
carcinoma (15.2%), malignant mastocytosis
(13.3%), fibrosarcoma (11.6%), and fibromyx-
osarcoma (11.1%). The findings showed that the
right side (17.4%), left side (14.1%), and both
sides (0.3%) of the breast were mostly affected.
However, this finding was inconclusive because
approximately 68.2% of the data that stated the
affected side was not available. Nearly all cases
(94.7%) presented with malignant cells. From
this result, we could infer that most women
diagnosed with breast cancer presented with
malignant tumors which implied late presentation.
Most women only come for screening at the time
when other body parts have been affected, which
would account for an increased mortality rate.
Educational intervention on breast self-
examination among women of all age groups
might be the best approach to avoid late
presentation.
Limitations
Other sociodemographic characteristics such as
educational level, socioeconomic status, marital
status, ethnicity, and residence (rural/urban) were
unavailable for in-depth analysis and comparison.
Availability of this information could have made
Table 3. Association between age and breast cancer classification. 
Variable Malignant Benign Fisher’s P-value
Age group (years) n % n % exact test
<20 1 0.3 2 10.0 9.477 0.011*
20-39 141 42.6 7 35.0
≥40 189 57.1 11 55.0
*significant at P<0.05                    
Deborah Tolulope Esan et al.
Middle East J Cancer 2018; 9(4): 311-317316
it possible to determine other factors responsible
for the observed frequencies of breast cancer.
Studies have shown that women with high
socioeconomic status had a 20% to 30%
significantly higher incidence but 30% to 40%
lower fatality compared with women with the
lowest socioeconomic status.15,29 Breast cancer
rates also varied by ethnicity in the US16 but were
independent of ethnicity in other studies.13,29
Information on the site of tumor, tumor grade, and
other tumor characteristics were also missing.
Recommendations
The incidence of breast cancer in Nigeria
(26.7%) and West Africa (26.4%) is a growing
public health concern.2,24 The mortality rate from
breast cancer in Nigeria (19.5%) and West Africa
(21.0%) present a tremendous problem.2,24 Efforts
should be made to address this burden through
awareness campaigns. Annually, on February 4th,
the International Union against Cancer (UICC)
leads a World Cancer Day to raise awareness of
cancer prevention.30 It is important that the
Nigerian government and non-governmental
organizations engage in periodic awareness
campaigns for breast cancer prevention.
Mammography screening should be made
available, affordable, and accessible to all age-
groups. Resources should also be made available
for early detection and treatment of breast cancer
cases. This will increase the survival rate for
breast cancer among women. Reduction or
elimination of exposure to cancer-causing factors
through effective tobacco control measures,
reduction of excessive alcohol consumption,
dietary intervention, reduction in occupational
exposure to carcinogens, and maintenance of
healthy body weight and physical activity30 will
have a considerable impact on reducing the
incidence and mortality rates of breast cancer in
Nigeria. More studies should be conducted to
ascertain the incidence, mortality, and survival
rates of breast cancer among women in Ekiti
state. A cancer registry should be established in the
state with mandatory compliance for case
reporting.
Conclusion
This study established that the trend of breast
cancer among women who attended FETHI
shifted from the middle age group to young adults.
The findings of the study revealed that the most
affected age group was between 20-39 years
which constituted a larger percentage of the adult
population. It could be deduced that
adenocarcinoma was the most common type of
breast cancer seen in this health facility. The
majority of breast cancer cases that presented
were malignant, which revealed late presentation
of the disease.
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